We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

2201:TSEMorinaga & Co., Ltd. Analysis

Data as of 2026-05-14 - not real-time

NT$27.30

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

The stock is trading below its short‑term moving average while the medium‑term average remains higher, indicating a bearish price bias. Volume has been trending down, and the RSI sits near the midpoint, suggesting limited momentum. The MACD histogram has turned positive despite the line itself being negative, hinting at a tentative technical rebound, but price remains close to a defined support zone. Market sentiment is marked by extreme greed, which may be inflating short‑term buying interest without addressing underlying fundamentals.
Fundamentally, the company faces declining revenue and thin profit margins, compounded by a very high debt‑to‑equity ratio that raises solvency concerns. Nevertheless, the discounted cash flow model points to a valuation substantially above the current market price, offering a sizable upside potential. Dividend yield is attractive, yet the payout ratio exceeds sustainable levels, questioning dividend reliability. Low beta implies limited systematic risk, while the consumer‑cyclical nature of the auto sector adds exposure to economic cycles. Overall, the stock appears undervalued from a valuation standpoint but carries notable operational and financial risks.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • price near technical support
  • decreasing volume
  • neutral momentum indicators

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • significant valuation gap to DCF fair value
  • attractive dividend yield despite payout concerns
  • low systematic risk as reflected by beta

Long Term

> 3 years
Positive
Model confidence: 6/10

Key Factors

  • potential upside from undervaluation
  • strategic exposure to emerging electric‑vehicle opportunities
  • high debt levels requiring monitoring

Key Metrics & Analysis

Financial Health

Revenue Growth-10.80%
Profit Margin1.35%
P/E Ratio29.4
ROE3.82%
ROA1.05%
Debt/Equity252.52
P/B Ratio0.5
Op. Cash FlowNT$19.0B
Free Cash FlowNT$21.7B

Technical Analysis

TrendBearish
RSI47.4
SupportNT$26.75
ResistanceNT$28.50
MA 20NT$27.34
MA 50NT$27.60
MA 200NT$32.02
MACDBullish
VolumeDecreasing
Fear & Greed Index89.46

Valuation

Fair ValueNT$64.03
Target PriceNT$36.00
Upside/Downside31.87%
GradeUndervalued
TypeValue
Dividend Yield2.03%

Risk Assessment

Beta0.16
Volatility25.55%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.